Skip to main content

Correlation of Dose Intensity and Prognosis in Adjuvant Chemotherapy: An Extended Controversy

  • Conference paper
Adjuvant Therapy of Primary Breast Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 115))

Abstract

In animal model systems, the outcome of chemotherapy depends upon drug dose, tumor sensitivity, and tumor burden. In animals, optimum treatment can be determined by treating beyond lethal toxicity. This is not possible in humans, where attempts to define optimum treatment have resulted in many schedules and combinations, and attempts to avoid serious toxicity have produced many schemes to reduce doses and delay treatment. However, these schedules and schemes have obscured dose-response relationships and have led to confusion. Dose-response relationships can be rediscovered and the confusion can be cleared by expressing all treatments in terms of how much drug is given per unit time. This is dose intensity (Green and Dawson 1980). Dose intensity may be calculated from intended drug doses (“projected dose intensity”) or from doses received after reductions and delays because of toxicity (“received dose intenstiy”) (Hryniuk and Bush 1984).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Beretta G, Tabiadon D, Tedeschi L et al. (1986) Front line treatment with CMF variations for advanced breast carcinoma. A randomized study. Proc Am Soc Clin Oncol 5: 77

    Google Scholar 

  • Bonadonna G, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10–15

    Article  PubMed  CAS  Google Scholar 

  • Carde P, MacKintosh FP, Rosenberg SA (1983) A dose and time response analysis of the treatment of Hodgkin’s disease with MOPP chemotherapy. J Clin Oncol 1: 146–153

    PubMed  CAS  Google Scholar 

  • Carmo-Pereira J, Costa FO, Henriques V et al. (1986 a) A randomized trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone in advanced breast cancer. Cancer Chemother Pharmacol 17: 87–90

    Article  PubMed  CAS  Google Scholar 

  • Carmo-Pereira J, Costa FO, Henriques V et al. (1986b) Advanced breast carcinoma: a comparison of two dose levels of Adriamycin. Proc Am Soc Clin Oncol 5: 56

    Google Scholar 

  • Cooper RG, Holland JF, Glidewell O (1979) Adjuvant chemotherapy of breast cancer. Cancer 44: 793–8

    Article  PubMed  CAS  Google Scholar 

  • Coppin CML (1987) The description of chemotherapy delivery: options and pitfalls. Semin Oncol 14 (4): 34–42

    PubMed  CAS  Google Scholar 

  • Goodyear M, Hryniuk W, Clark D et al. (1985) Relationship of dose intensity (DI) to outcome in chemotherapy of advanced breast carcinoma. Proc Am Soc Clin Oncol 4: 61

    Google Scholar 

  • Green J A, Dawson AA (1980) Measurement of drug dosage intensity in MVPP therapy in Hodgkin’s disease. Br J Clin Pharmacol 9: 511–514

    PubMed  CAS  Google Scholar 

  • Hryniuk W, Bush H (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2 (11): 1281–8

    PubMed  CAS  Google Scholar 

  • Hryniuk W, Levine M (1986) Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast carcinoma. J Clin Oncol 4: 1162–1170

    PubMed  CAS  Google Scholar 

  • Hryniuk W (1987) Average relative dose intensity and the impact on design of clinical trials. Semin Oncol 14: 65–74

    PubMed  CAS  Google Scholar 

  • Hryniuk W, Bonadonna G, Valagussa P ( 1987 a) The effect of dose intensity in adjuvant chemotherapy. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer, vol 5. Grune and Stratton, Orlando, Florida, pp 13–23

    Google Scholar 

  • Hryniuk W, Figueredo A, Goodyear M (1987 b) Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. Semin Oncol 14, (4): 3–11

    PubMed  CAS  Google Scholar 

  • Ludwig Breast Cancer Study Group (1985) A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. Cancer Res 45: 4454–4459

    Google Scholar 

  • Nissen-Meyer R, Kjellgren K, Malmio K et al. (1978) Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer. The Scandinavian Adjuvant Chemotherapy Study Group (SACSG) project. Cancer 41: 2088–2098

    Article  PubMed  CAS  Google Scholar 

  • Pater JL (1987) Implications of dose intensity for cancer clinical trials. Semin Oncol 14, (4),

    Google Scholar 

  • Suppl 4 (December)]: 1–2

    Google Scholar 

  • Samson JK, Rivkin SE, Jones SE et al. (1984) Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group (SWOG) project. Cancer 53: 1029–1035

    Article  PubMed  CAS  Google Scholar 

  • Tancini G, Bonadonna G, Valagussa P et al. (1983) Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles. J Clin Oncol 1: 2–10

    PubMed  CAS  Google Scholar 

  • Tannock IF, Boyd NF, Perrault DJ (1987) Randomized trial of two doses of CMF chemotherapy for metastatic breast cancer. Proc Am Soc Clin Oncol 6: 50

    Google Scholar 

  • Tormey DC, Gelman R, Band PR (1982) Comparison of induction chemotherapies for metastatic breast cancer. Cancer 50: 1235–1244

    Article  PubMed  CAS  Google Scholar 

  • Wood WC (1983) Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients. Breast Cancer Res Treat 3: 39–43

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Hryniuk, W.M. (1989). Correlation of Dose Intensity and Prognosis in Adjuvant Chemotherapy: An Extended Controversy. In: Senn, HJ., Goldhirsch, A., Gelber, R.D., Osterwalder, B. (eds) Adjuvant Therapy of Primary Breast Cancer. Recent Results in Cancer Research, vol 115. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83337-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83337-3_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83339-7

  • Online ISBN: 978-3-642-83337-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics